Cdk/Cyclin complexes drive progression through the eukaryotic cell cycle. Entry into mitosis is triggered by Cdk1 (Cdc2)/Cyclin B complexes, while M phase exit requires Cyclin B degradation and dephosphorylation of mitotic phosphoproteins. The destruction of Cyclin B at M phase exit is driven by the APC (anaphase promoting complex), a multi-protein E3 ubiquitin ligase, which ubiquitylates Cyclin B and promotes its proteasomal degradation. Multiple factors cooperate to prevent premature activation and ensure timely inactivation of the APC. In vertebrate eggs, which are arrested in M phase for prolonged periods of time, the APC is restrained by an activity known as Cytostatic Factor (CSF). Recent findings in both Xenopus and mouse eggs have strongly implicated Emi2 protein as a critical component of CSF activity, responsible for direct inhibition of the APC. We do not understand precisely how Emi2 effects APC inhibition, though we have recently found that Emi2 appears to act catalytically, rather than stoichiometrically, as is generally believed. Moreover, our data indicate that Emi2 function is inhibited, at least in part, through direct Cdc2-mediated phosphorylation, though the nature of the phosphatase complexes that counter this to activate Emi2 function are unknown.
The aims of this proposal are to elucidate the mechanism(s) of APC inhibition by Emi2 and to determine how Emi2 is regulated by CSF. This understanding is critical in that inappropriate APC activation at meiotic exit can lead to errors in chromosome segregation and severe developmental abnormalities underlying a range of birth defects.

Public Health Relevance

This proposal focuses on the regulation of exit from mitosis. Defects in the anaphase promoting complex (APC) or its regulators may cause aberrant mitotic exit, leading to abnormal chromosome segregation. In somatic cells, this can result in aneuploidy and carcinogenesis and in germ cells such errors can lead to birth defects. By understanding fully the regulation of the APC, we hope to develop the means to either prevent or rectify these errors.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
5R01GM088175-02
Application #
7933641
Study Section
Special Emphasis Panel (ZRG1-BST-Z (90))
Program Officer
Hamlet, Michelle R
Project Start
2009-09-29
Project End
2011-08-31
Budget Start
2010-09-01
Budget End
2011-08-31
Support Year
2
Fiscal Year
2010
Total Cost
$303,893
Indirect Cost
Name
Duke University
Department
Pharmacology
Type
Schools of Medicine
DUNS #
044387793
City
Durham
State
NC
Country
United States
Zip Code
27705
Horn, Sarah R; Thomenius, Michael J; Johnson, Erika Segear et al. (2011) Regulation of mitochondrial morphology by APC/CCdh1-mediated control of Drp1 stability. Mol Biol Cell 22:1207-16
Tang, Wanli; Wu, Judy Qiju; Chen, Chen et al. (2010) Emi2-mediated inhibition of E2-substrate ubiquitin transfer by the anaphase-promoting complex/cyclosome through a D-box-independent mechanism. Mol Biol Cell 21:2589-97